Trial intelligence / Profile preview

thrombostim in Recalcitrant Venous Stasis Ulcers

NCT02802995Phase 3Terminated

Sponsor
University of the Witwatersrand
Start
May 2016
Primary completion
May 2017
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of Thrombostim in venous stasis ulcer, sponsored by University of the Witwatersrand. Started May 2016; status: terminated.

02

Drugs

Thrombostim
03

Conditions

venous stasis ulcer

Beyond the preview

Go deeper on NCT02802995.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02802995.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call